Clinical implication of 14-3-3 epsilon expression in gastric cancer

World J Gastroenterol. 2012 Apr 7;18(13):1531-7. doi: 10.3748/wjg.v18.i13.1531.

Abstract

Aim: To evaluate for the first time the protein and mRNA expression of 14-3-3ε in gastric carcinogenesis.

Methods: 14-3-3ε protein expression was determined by western blotting, and mRNA expression was examined by real-time quantitative RT-PCR in gastric tumors and their matched non-neoplastic gastric tissue samples.

Results: Authors observed a significant reduction of 14-3-3ε protein expression in gastric cancer (GC) samples compared to their matched non-neoplastic tissue. Reduced levels of 14-3-3ε were also associated with diffuse-type GC and early-onset of this pathology. Our data suggest that reduced 14-3-3ε may have a role in gastric carcinogenesis process.

Conclusion: Our results reveal that the reduced 14-3-3ε expression in GC and investigation of 14-3-3ε interaction partners may help to elucidate the carcinogenesis process.

Keywords: 14-3-3 epsilon; Gastric cancer; Gene expression; Protein expression; YWHAE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 14-3-3 Proteins / genetics
  • 14-3-3 Proteins / metabolism*
  • Adult
  • Female
  • Gastric Mucosa / pathology
  • Gastric Mucosa / physiology
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Male
  • Middle Aged
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / metabolism*
  • Stomach Neoplasms / pathology*
  • Stomach Neoplasms / physiopathology*

Substances

  • 14-3-3 Proteins